Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn how to unlock additional credit card perks. Enhance your benefits and enjoy more rewards!
15,641 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
XRP has long been tied to a grand bridge-currency dream. This article presents a bull case that even skeptics should ...
Two billionaire investors, two very different plays on Alphabet. One backs a measured, Buffett-like approach; the oth...
The Pentagon’s fight with Anthropic has become a landmark test of how the U.S. will regulate powerful AI. Markets and...
Many seniors assume you must collect Social Security to get tax relief, but that isn’t always true. Here’s how the ne...
A significant share of women say their gender slows their progress, affecting careers and money. Learn practical stra...
Two stalwarts of the insurance world compete for a spot in a 2026 portfolio. This article breaks down Lincoln Nationa...
Looking to find a better space stock: spacemobile? This guide breaks down AST SpaceMobile and Rocket Lab, weighing te...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
Nio just hit a landmark: a swapped million batteries week. The feat showcases its battery-swapping edge, but does it ...
Legislation known as the Clarity Act moves through Congress, aiming to legalize real estate tokenization. If enacted,...
Synopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...